Target intelligence / Profile preview

Cathepsin L family member 3, pseudogene (CTSL3P)

Target
CTSL3P
Molecular classification
Other (pseudogene), Cysteine protease (family, but this entry is a pseudogene)
01

Overview

Cathepsin L family member 3, pseudogene (CTSL3P) is a transcribed unprocessed pseudogene located on chromosome 9q21.33.[1] It is related by sequence to the cathepsin L family of cysteine proteases, which are lysosomal endopeptidases important for intracellular protein degradation, antigen processing, tumor invasion, and other processes[3]. However, the CTSL3P locus is currently labeled as a pseudogene, as no functional protein product or enzymatic activity has been confirmed[7][4]. Certain sequence changes in the gene (such as the replacement of a stop codon by a tryptophan in some forms) have raised the possibility it could have been functional in the past, but there is no evidence of current protein expression or function[5]. Because it does not produce a protein, it is not considered a therapeutic target, biomarker, or risk locus for any disease to date. The designation of CTSL3P as a pseudogene may evolve if future studies reveal transcriptional or regulatory functions. Assessment of correctness: This entry is primarily a pseudogene. It is not a protein-coding gene or recognized as a functional target in drug discovery. For therapeutic, functional, or disease associations, refer instead to active members of the cathepsin L family such as Cathepsin L (CTSL)[3][2][7].

Other names
CTSL3HCTSL-sCathepsin L3 pseudogenePutative inactive cathepsin L-like protein CTSL3PCTSL3PHCTSL-S

Beyond the preview

Go deeper on Cathepsin L family member 3, pseudogene (CTSL3P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cathepsin L family member 3, pseudogene (CTSL3P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call